Interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
Myeloma 2017 day 1 highlights: immunotherapy advances, a new MM subtype and liquid biopsies
Gareth Morgan et al.
Ibrutinib combination therapy in CLL: overview of the data so far
The future of AML treatment? Progress in IDH1/2 inhibitors for AML
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?